text.skipToContent text.skipToNavigation
Need help? Please contact us
You searched for "natural killer cells"
Too many choices? Use the filter option on the left to narrow your product listing.
271-280 of 779 results
  • Human B Cell Nucleofector™ Kit
    Compare
    Human B Cell Nucleofector™ Kit
    Catalog #: VPA-1001
    For efficient transfection of primary human B cells in the NucleofectorTM I/II/2b Device
    Sales unit: items
    ST
  • SmGM™- 2 Smooth Muscle Cell Growth Medium -2 BulletKit™
    Compare
    SmGM™- 2 Smooth Muscle Cell Growth Medium -2 BulletKit™
    Catalog #: CC-3182

    Culture system containing SmBMTM Basal Medium (CC-3181) and SmGMTM-2 SingleQuotsTM supplements (CC-4149) required for growth of Smooth Muscle Cells

    Sales unit: kit
    SA
  • SCGM™ Stromal Cell Growth Medium SingleQuots™ Supplements and Growth Factors
    Compare
    SCGM™ Stromal Cell Growth Medium SingleQuots™ Supplements and Growth Factors
    Catalog #: CC-4181
    SCGMTM Stromal Cell SingleQuotsTM Kit
    Sales unit: each
    EA
  • EBM™ Endothelial Cell Growth Basal Medium, 500 mL
    Compare
    EBM™ Endothelial Cell Growth Basal Medium, 500 mL
    Catalog #: CC-3121

    Basal media required for growth of Endothelial cells, 500 mL (supplements and growth factors sold separately)

     

    Sales unit: each
    EA
  • OsteoImage™ Mineralization Assay, 500 Test
    Compare
    OsteoImage™ Mineralization Assay, 500 Test
    Catalog #: PA-1503

    OsteoImageTM Mineralization Assay is a rapid, fluorescent in vitro assay for assessing bone cell mineralization, 500 tests. 

    Sales unit: each
    EA
  • P3 Primary Cell 384-well Nucleofector<sup class=reg>®</sup> Kit
    Compare
    P3 Primary Cell 384-well Nucleofector® Kit
    Catalog #: V5SP-3002
    For high-throughput transfection of primary cells, e.g. human T cells, DCs or CD34, when working with the 384-well Nucleofector® System.
    Sales unit: kit
    SA
  • P3 Primary Cell 96-well Nucleofector® Kit
    Compare
    P3 Primary Cell 96-well Nucleofector® Kit
    Catalog #: V4SP-3096
    For medium-throughput transfection of primary cells, e.g. human T cells, CD34 or rat neurons, when working with the 4D-Nucleofector® 96-well Unit.
    Sales unit: kit
    SA
  • P3 Primary Cell 384-well Nucleofector™ Kit
    Compare
    P3 Primary Cell 384-well Nucleofector™ Kit
    Catalog #: V5SP-3010
    For high-throughput transfection of primary cells, e.g. human T cells, DCs or CD34, when working with the 384-well HT NucleofectorTM System.
    Sales unit: items
    ST
  • Mouse C57 Brain Mixed Astrocytes
    Compare
    Mouse C57 Brain Mixed Astrocytes
    Catalog #: M-ASM-330

    Cryopreserved ampule of Mouse C57 Mixed Astrocytes containing ≥ 1 million cells

    Sales unit: each
    EA
  • P-HEK - Diseased Human Epidermal Keratinocytes (Non-Lesion)
    Compare
    P-HEK - Diseased Human Epidermal Keratinocytes (Non-Lesion)
    Catalog #: 00219735
    Limited Edition Epidermal Keratinocytes from Psoriasis Donor (Non-Lesion Site Derived)
    Sales unit: Ampule
    AMP
1-10 of 1103 results
  • Natural Killer Cells Infographic
    Natural Killer cells have an innate ability to recognize and destroy non-self cells.
  • 3D Natural Killer Cell-mediated Cytotoxicity Assay
    Lonza White Paper
  • 3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay
    Watch Video
  • Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity Assay
    Protocol instructions
  • Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force Awakens
    Poster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
  • Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cells
    A strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
  • NK Cell Assay using 3D Bioprinted Tumor Models
    This white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
  • TechSheet - Poietics™ Human Immune System Cells
    Technical Product Information Sheet
  • CAR T cells in Cancer Therapy
    A poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.